4//SEC Filing
Coleman Mark 4
Accession 0000950170-25-084560
CIK 0001579428other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:00 PM ET
Size
7.4 KB
Accession
0000950170-25-084560
Insider Transaction Report
Form 4
Coleman Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-06+3,166→ 3,166 totalExercise: $111.91Exp: 2035-06-06→ Common Stock (3,166 underlying) - Award
Restricted Stock Units
2025-06-06+1,429→ 1,429 total→ Common Stock (1,429 underlying)
Footnotes (3)
- [F1]The options vest in full on the one-year anniversary of the date of grant, June 6, 2026.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001658379
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:00 PM ET
- Size
- 7.4 KB